DUBLIN--(BUSINESS WIRE)--The "Nucleic Acid Isolation and Purification Market Analysis Report By Product, By Type (DNA, RNA), By Application (Drug Discovery, Oncology), By Method, By End Use, By Region, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.
The global nucleic acid isolation & purification market size is expected to reach USD 3.6 billion by 2025, exhibiting a CAGR of 6.8% during the forecast period.
Decreasing cost of genetic sequencing, ongoing developments in genetics, personalized medicine, and diagnostics, and increasing automation and technological advancements in instruments and tools used for isolation and purification of polynucleotides are some of the key factors driving this market.
North America currently holds the largest share in this market, followed by Europe. Asia is likely to register the fastest growth owing to its rapidly expanding economy, rising healthcare expenditure, and increasing government financing in research projects.
High cost of instruments that are utilized as part of the methodology for isolation and purification of nucleic acids is one of the key challenges in the market, especially in emerging countries.
Major players in this market include QIAGEN; Danaher Corporation; Thermo Fisher Scientific, Inc.; Agilent Technologies Inc.; Bio-Rad Laboratories Inc.; and Promega Corporation.
Key Topics Covered:
Chapter 1 Research Methodology & Scope
Chapter 2 Executive Summary
Chapter 3 Market Variables, Trends & Scope
Chapter 4 Market Categorization: Product Estimates & Trend Analysis
Chapter 5 Market Categorization: Type Estimates & Trend Analysis
Chapter 6 Market Categorization: Method Estimates & Trend Analysis
Chapter 7 Market Categorization: Application & Trend Analysis
Chapter 8 Market Categorization: End Use & Trend Analysis
Chapter 9 Market Categorization: Regional Estimates & Trend Analysis
Chapter 10 Competitive Landscape
- ThermoFisher Scientific, Inc.
- Illumina, Inc.
- F Hoffmann-La Roche Ltd.
- Merck KGaA
- Agilent Technologies
- Bio-Rad Laboratories, Inc.
- General Electric Company (GE healthcare)
- Takara Bio USA Holdings, Inc.
- Promega Corporation
- Norgen Biotek Corp.
For more information about this report visit https://www.researchandmarkets.com/research/fpxdp6/global_nucleic?w=4